1. Home
  2. INM vs BHFAN Comparison

INM vs BHFAN Comparison

Compare INM & BHFAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • BHFAN
  • Stock Information
  • Founded
  • INM 1981
  • BHFAN N/A
  • Country
  • INM Canada
  • BHFAN United States
  • Employees
  • INM N/A
  • BHFAN 1400
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • BHFAN Life Insurance
  • Sector
  • INM Health Care
  • BHFAN Finance
  • Exchange
  • INM Nasdaq
  • BHFAN Nasdaq
  • Market Cap
  • INM 4.3M
  • BHFAN N/A
  • IPO Year
  • INM N/A
  • BHFAN N/A
  • Fundamental
  • Price
  • INM $2.11
  • BHFAN $13.10
  • Analyst Decision
  • INM
  • BHFAN
  • Analyst Count
  • INM 0
  • BHFAN 0
  • Target Price
  • INM N/A
  • BHFAN N/A
  • AVG Volume (30 Days)
  • INM 39.2K
  • BHFAN N/A
  • Earning Date
  • INM 09-29-2025
  • BHFAN N/A
  • Dividend Yield
  • INM N/A
  • BHFAN N/A
  • EPS Growth
  • INM N/A
  • BHFAN N/A
  • EPS
  • INM N/A
  • BHFAN N/A
  • Revenue
  • INM $4,920,990.00
  • BHFAN N/A
  • Revenue This Year
  • INM N/A
  • BHFAN N/A
  • Revenue Next Year
  • INM N/A
  • BHFAN N/A
  • P/E Ratio
  • INM N/A
  • BHFAN N/A
  • Revenue Growth
  • INM N/A
  • BHFAN N/A
  • 52 Week Low
  • INM $1.72
  • BHFAN N/A
  • 52 Week High
  • INM $8.27
  • BHFAN N/A
  • Technical
  • Relative Strength Index (RSI)
  • INM 38.96
  • BHFAN 31.94
  • Support Level
  • INM $2.03
  • BHFAN $14.68
  • Resistance Level
  • INM $2.26
  • BHFAN $15.65
  • Average True Range (ATR)
  • INM 0.09
  • BHFAN 0.40
  • MACD
  • INM 0.01
  • BHFAN -0.23
  • Stochastic Oscillator
  • INM 29.63
  • BHFAN 11.61

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

Share on Social Networks: